Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses

被引:25
作者
Jordens, JZ
Lanham, S
Pickett, MA
Amarasekara, S
Abeywickrema, I
Watt, PJ
机构
[1] Univ Southampton, Dept Mol Med, Southampton SO16 6YD, Hants, England
[2] John Radcliffe Hosp, Publ Hlth Lab, Oxford OX3 9DU, England
[3] Natl STD AIDS Control Programme, Colombo, Sri Lanka
关键词
human papillomavirus; line blotting; molecular beacon primer; sequence detector system;
D O I
10.1016/S0166-0934(00)00195-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A novel method for the detection and typing of human papillomavirus (HPV) was developed using molecular beacon primers. The method is based on the use of HPV-specific primers containing a hairpin loop structure in which fluorescent donor and quencher groups are held in close proximity such that fluorescence is quenched. Amplification of the target sequence results in the opening of the loop and the resulting fluorescence can be detected on a sequence detector system (SDS) 7700 (Applied Biosystems), as used for TaqMan(TM) assays. Fluorescent amplicons were identified on the SDS 7700 and then typed by a single hybridisation with specific probes immobilised in lines on a nylon membrane and detected on a fluorescent scanner. This novel beacon primer method compared well with conventional PCR for cervical scrape specimens. The combination of the beacon primer method and reverse line blotting should enable large-scale population studies of HPV infection. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 21 条
  • [1] BECKER TM, 1994, JAMA-J AM MED ASSOC, V271, P1181, DOI 10.1001/jama.271.15.1181
  • [2] Screening for cervical cancer
    Cuzick, J
    Meijer, CJLM
    Walboomers, JMM
    [J]. LANCET, 1998, 351 (9113) : 1439 - 1440
  • [3] HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING
    CUZICK, J
    SZAREWSKI, A
    TERRY, G
    HO, L
    HANBY, A
    MADDOX, P
    ANDERSON, M
    KOCJAN, G
    STEELE, ST
    GUILLEBAUD, J
    [J]. LANCET, 1995, 345 (8964) : 1533 - 1536
  • [4] Cervical-cancer screening comes of age - or does it?
    Fricker, J
    [J]. LANCET, 1997, 350 (9083) : 1010 - 1010
  • [5] Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
    Gravitt, PE
    Peyton, CL
    Apple, RJ
    Wheeler, CM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 3020 - 3027
  • [6] Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
  • [7] PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN
    HILDESHEIM, A
    SCHIFFMAN, MH
    GRAVITT, PE
    GLASS, AG
    GREER, CE
    ZHANG, T
    SCOTT, DR
    RUSH, BB
    LAWLER, P
    SHERMAN, ME
    KURMAN, RJ
    MANES, MM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 235 - 240
  • [8] HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
  • [9] GROUP-SPECIFIC DIFFERENTIATION BETWEEN HIGH- AND LOW-RISK HUMAN PAPILLOMAVIRUS GENOTYPES BY GENERAL PRIMER-MEDIATED PCR AND 2 COCKTAILS OF OLIGONUCLEOTIDE PROBES
    JACOBS, MV
    HUSMAN, AMD
    VANDENBRULE, AJC
    SNIJDERS, PJF
    MEIJER, CJLM
    WALBOOMERS, JMM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (04) : 901 - 905
  • [10] Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay
    Josefsson, A
    Livak, K
    Gyllensten, U
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 490 - 496